Genomic Correlate of Exceptional Erlotinib Response in Head and Neck Squamous Cell Carcinoma

Eliezer M. Van Allen(Dana-Farber Cancer Institute), Jennifer R. Grandis(University of California, San Francisco), Yu Du(Wuhan Children's Hospital), Jonas T. Johnson(University of Pittsburgh), Gordon B. Mills(The University of Texas MD Anderson Cancer Center), Ann Marie Egloff(Brigham and Women's Hospital), Scott L. Carter(Broad Institute), Vivian Wai Yan Lui(Chinese University of Hong Kong), David A. Close(University of Pittsburgh), Aaron McKenna(Dartmouth College), Umamaheswar Duvvuri(City University of New York), Levi A. Garraway(Broad Institute), Eva M. Goetz(Broad Institute), Nikhil Wagle(Dana-Farber Cancer Institute), Nicolas Stransky(Broad Institute), Paul A. Johnston(University of South Carolina), Simion I. Chiosea(University of Pittsburgh), Julie E. Bauman(George Washington University), Breean R. Gilbert(The University of Texas MD Anderson Cancer Center), Carrie Sougnez(Broad Institute), Yan Zeng(The University of Texas MD Anderson Cancer Center), Hua Li(Fujian University of Traditional Chinese Medicine), Lin Wang(Heilongjiang University), Fan Zhang(Wenzhou Medical University), Gad Getz(Broad Institute), Kelsey P. Pendleton(University of Pittsburgh), Todd R. Golub(Broad Institute)
JAMA Oncology
March 5, 2015
Cited by 47


Related Papers